TY  - JOUR
T1  - REsponse to etanercept in juvenile idiopathic arthritis
AU  - Pang H, Wu X, Xu J
Y1  - 2012/03/21
N1  - 10.1001/jama.2012.328
JO  - JAMA
SP  - 1140
EP  - 1141
VL  - 307
IS  - 11
N2  - 
To the Editor: The study presented by Dr Otten and colleagues assessed factors associated with treatment response to etanercept in patients with juvenile idiopathic arthritis (JIA).1 They found that approximately one-third of the patients with JIA achieved an excellent response, which was associated with low baseline disability scores, low numbers of disease-modifying antirheumatic drugs used before initiating etanercept, and younger age at onset of JIA. One-third achieved a poor response, which was associated with systemic JIA and female sex.1

SN  - 0098-7484
M3  - doi: 10.1001/jama.2012.328
UR  - http://dx.doi.org/10.1001/jama.2012.328
ER  -